Evidence map›Paper›PMID 32898178›Full record

ArticlePLoS pathogens2020

The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.

Olivia A Vogel, Julianna Han, Chieh-Yu Liang, Santhakumar Manicassamy, Jasmine T Perez, Balaji Manicassamy

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Evolution of Engineered ADAR-Based RNA Editing Systems.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of ADAR1 in human pathophysiology.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Review
  13. RNA editing and immune control: from mechanism to therapy.Current opinion in genetics & development · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Olivia A VogelDepartment of Microbiology, University of Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-7918-0395
Julianna HanDepartment of Microbiology, University of Chicago, Chicago, Illinois, United States of America.
Chieh-Yu LiangDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.
Santhakumar ManicassamyCancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Augusta University, Augusta, Georgia.ORCID 0000-0002-2203-3917
Jasmine T PerezDepartment of Microbiology, University of Chicago, Chicago, Illinois, United States of America.
Balaji ManicassamyDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0003-1964-0967
University of Chicago · USUniversity of Iowa · USAugusta University Health · US

Funding

Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
ENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01R01AI127775 · NIAID · UNIVERSITY OF IOWA · PI MANICASSAMY, BALAJI · 2018 to 2022
$2.8M
Modulation of Influenza Virus Replication and Fitness by Adenosine DeaminasesR01AI123359 · NIAID · UNIVERSITY OF IOWA · PI MANICASSAMY, BALAJI · 2016 to 2020
$1.9M
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF PathR01DK097271 · NIDDK · AUGUSTA UNIVERSITY · PI MANICASSAMY, SANTHAKUMAR · 2012 to 2016
$1.6M
Regulation of colitis associated with acute kidney injury by the Wnt pathwayR01DK123360 · NIDDK · AUGUSTA UNIVERSITY · PI MANICASSAMY, SANTHAKUMAR · 2020 to 2023
$1.4M
NIAID NIH HHS R01 AI123359NIAID NIH HHS R01 AI127775NIDDK NIH HHS R01 DK097271NIDDK NIH HHS R01 DK123360NIGMS NIH HHS T32 GM007183
6 · The paper itself

Abstract

Signaling through retinoic acid inducible gene I (RIG-I) like receptors (RLRs) is tightly regulated, with activation occurring upon sensing of viral nucleic acids, and suppression mediated by negative regulators. Under homeostatic conditions aberrant activation of melanoma differentiation-associated protein-5 (MDA5) is prevented through editing of endogenous dsRNA by RNA editing enzyme Adenosine Deaminase Acting on RNA (ADAR1). In addition, ADAR1 is postulated to play pro-viral and antiviral roles during viral infections that are dependent or independent of RNA editing activity. Here, we investigated the importance of ADAR1 isoforms in modulating influenza A virus (IAV) replication and revealed the opposing roles for ADAR1 isoforms, with the nuclear p110 isoform restricting versus the cytoplasmic p150 isoform promoting IAV replication. Importantly, we demonstrate that p150 is critical for preventing sustained RIG-I signaling, as p150 deficient cells showed increased IFN-β expression and apoptosis during IAV infection, independent of RNA editing activity. Taken together, the p150 isoform of ADAR1 is important for preventing sustained RIG-I induced IFN-β expression and apoptosis during viral infection.

Indexed as

ApoptosisSignal TransductionVirus ReplicationA549 CellsAdenosine DeaminaseDEAD Box Protein 58HEK293 CellsHumansInfluenza A virusInfluenza, HumanIsoenzymesReceptors, ImmunologicRNA-Binding ProteinsADAR protein, humanAdenosine DeaminaseDEAD Box Protein 58IsoenzymesReceptors, ImmunologicRIGI protein, humanRNA-Binding Proteins

Identifiers

PMID32898178
PMCPMC7500621
OpenAlexW3084293983

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.